<DOC>
	<DOC>NCT00997113</DOC>
	<brief_summary>This is a randomized clinical trial of deep procedural sedation with propofol with and without supplemental alfentanil. Patients will be assessed for total and fractionated serum catecholamines before and after the procedure in addition to usual procedural sedation outcomes parameters to assess the adrenergic effect of propofol sedation without supplemental opioid.</brief_summary>
	<brief_title>Stress During Deep Sedation With Propofol With and Without Alfentanil</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Alfentanil</mesh_term>
	<criteria>patients who will require deep procedural sedation with propofol in the ED age &lt;18 intoxication unable to provide informed consent allergy to propofol or alfentanil pregnant ASA physical status score &gt; 2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>propofol</keyword>
	<keyword>alfentanil</keyword>
	<keyword>procedural sedation</keyword>
	<keyword>stress biomarkers</keyword>
	<keyword>Deep procedural sedation in the ED</keyword>
</DOC>